Abbott, DexCom settlement 'not a complete surprise,' Wells Fargo says

Wells Fargo notes Abbott (ABT) and DexCom (DXCM) revealed that, on December 20, they had settled and entered into a cross-licensing agreement to resolve all outstanding patent litigation in the United States and Europe for 10 years. Under the…